Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02699203
Other study ID # H15-02638
Secondary ID
Status Completed
Phase N/A
First received February 22, 2016
Last updated March 16, 2017
Start date December 2015
Est. completion date July 1, 2016

Study information

Verified date February 2016
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In addition to its role as the major regulator of glucose uptake into peripheral tissues, the hormone insulin is also a primary regulator of fat storage and fat burning of the body. Mechanistic animal studies have shown that high insulin may be the initial trigger for weight gain and be the proximal cause of obesity. There is currently no quick or non-invasive way of measuring insulin as research and clinical techniques require collection of a blood sample followed by a complicated and costly biochemical assay. The investigators will test the hypothesis that insulin levels can be accurately measured in saliva in humans following meals that elicit high and low blood insulin responses. Findings will help determine if insulin can be use as a valid fluid to track insulin changes in humans.


Description:

Lean and obese healthy participants will consume both a high carbohydrate meal and a low carbohydrate meal designed to elicit different insulin responses on two separate occasions. Blood samples and saliva samples will be collected for 2 hours following each meal and insulin will be measured in both plasma and saliva. The relationship between plasma and saliva insulin following the two meals will be assessed.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date July 1, 2016
Est. primary completion date July 1, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Body mass index between 18.5-24.9 or over 30.0 kg/m2

Exclusion Criteria:

- Diabetes or other medical conditions affecting glucose or insulin levels

- Smoker

- Competitive athlete

- Vegan or vegetarian

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
High-carbohydrate meal
Participants will consume a high-carbohydrate low fat meal. The macronutrients content will be 55% carbohydrate, 25% protein and 20% fat providing 400-500 kcal. Between interventions there will be at least a 48-hours washout, where participants are encouraged to return to their baseline dietary habits.
Low-carbohydrate meal
Participants will consume a low-carbohydrate high fat meal. The macronutrients content will be 10% carbohydrate, 25% protein and 65% fat and will provide 400-500 kcal (matched to the high carbohydrate meal). Between interventions there will be at least a 48-hours washout, where participants are encouraged to return to their baseline dietary habits.

Locations

Country Name City State
Canada University of British Columbia, Okanagan. Kelowna British Columbia

Sponsors (2)

Lead Sponsor Collaborator
University of British Columbia Mitacs

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peak plasma insulin level Peak plasma insulin concentration in high carbohydrate versus low carbohydrate arm. 0-120 minutes
Secondary Plasma insulin area under the curve Area under the curve for plasma insulin in high carbohydrate versus low carbohydrate arm. 0-120 minutes
Secondary Relationship between peak saliva and peak plasma insulin Correlation of peak plasma and peak saliva insulin in high carbohydrate versus low carbohydrate arm. 0-120 minutes
Secondary Timing of peak saliva and peak plasma insulin Timing of peak plasma and peak saliva insulin in high carbohydrate versus low carbohydrate arm. 0-120 minutes
Secondary Relationship between saliva insulin area under the curve and plasma insulin area under the curve Correlation between area under the curve for plasma and saliva insulin in high carbohydrate versus low carbohydrate arm. 0-120 minutes
Secondary Peak saliva insulin level Peak salivary insulin in high carbohydrate versus low carbohydrate arm 0-120 minutes
Secondary Saliva insulin area under the curve Area under the curve for salivary insulin in high carbohydrate versus low carbohydrate arm 0-120 minutes
See also
  Status Clinical Trial Phase
Completed NCT03142633 - MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03383822 - Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT04203238 - Potato Research for Enhancing Metabolic Outcomes N/A
Recruiting NCT03658564 - Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance N/A
Completed NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics Phase 4
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03627104 - Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A
Active, not recruiting NCT03288025 - Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE) N/A
Completed NCT03809182 - Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels. Phase 4
Completed NCT01809288 - Identifying Risk for Diabetes and Heart Disease in Women
Completed NCT04642482 - Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity Phase 4
Terminated NCT03278236 - Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Not yet recruiting NCT05540249 - Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG N/A
Withdrawn NCT04741204 - Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer Phase 4